Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lymphoma × abrysvo × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 378 Rituximab 325 Etoposide 189 Vincristine 174 Filgrastim 171 Doxorubicin 167 Prednisone 141 Radiotherapy 135 Cytarabine 132 fludarabine phosphate 119 Methotrexate 109 Melphalan 109 Peripheral Blood Stem Cell Transplantation 106 fludarabine 99 Busulfan 83 Dexamethasone 74 Carmustine 63 Granulocyte Colony-Stimulating Factor 60 Tacrolimus 58 Gemcitabine 56 Mycophenolic Acid 55 Whole-Body Irradiation 54 Bendamustine Hydrochloride 54 Antilymphocyte Serum 54 Cyclosporine 51 Lenalidomide 50 Ifosfamide 50 Bortezomib 48 Methylprednisolone 42 Leucovorin 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡